• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-1α作为胃癌特征的强效诱导剂。

The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.

作者信息

Ucaryilmaz Metin Cemre, Ozcan Gulnihal

机构信息

Graduate School of Health Sciences, Koç University, 34450 Istanbul, Turkey.

Department of Medical Pharmacology, School of Medicine, Koç University, 34450 Istanbul, Turkey.

出版信息

Cancers (Basel). 2022 May 30;14(11):2711. doi: 10.3390/cancers14112711.

DOI:10.3390/cancers14112711
PMID:35681691
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9179860/
Abstract

Hypoxia is the principal architect of the topographic heterogeneity in tumors. Hypoxia-inducible factor-1α (HIF-1α) reinforces all hallmarks of cancer and donates cancer cells with more aggressive characteristics at hypoxic niches. HIF-1α potently induces sustained growth factor signaling, angiogenesis, epithelial-mesenchymal transition, and replicative immortality. Hypoxia leads to the selection of cancer cells that evade growth suppressors or apoptotic triggers and deregulates cellular energetics. HIF-1α is also associated with genetic instability, tumor-promoting inflammation, and escape from immunity. Therefore, HIF-1α may be an important therapeutic target in cancer. Despite that, the drug market lacks safe and efficacious anti-HIF-1α molecules, raising the quest for fully unveiling the complex interactome of HIF-1α in cancer to discover more effective strategies. The knowledge gap is even wider in gastric cancer, where the number of studies on hypoxia is relatively low compared to other well-dissected cancers. A comprehensive review of the molecular mechanisms by which HIF-1α induces gastric cancer hallmarks could provide a broad perspective to the investigators and reveal missing links to explore in future studies. Thus, here we review the impact of HIF-1α on the cancer hallmarks with a specific focus on gastric cancer.

摘要

缺氧是肿瘤地形异质性的主要成因。缺氧诱导因子-1α(HIF-1α)强化了癌症的所有特征,并使癌细胞在缺氧微环境中具有更强的侵袭性。HIF-1α有力地诱导持续的生长因子信号传导、血管生成、上皮-间质转化和复制永生。缺氧导致选择逃避生长抑制因子或凋亡触发因子的癌细胞,并使细胞能量代谢失调。HIF-1α还与基因不稳定、肿瘤促进性炎症和免疫逃逸有关。因此,HIF-1α可能是癌症的一个重要治疗靶点。尽管如此,药物市场缺乏安全有效的抗HIF-1α分子,这就需要全面揭示HIF-1α在癌症中的复杂相互作用组,以发现更有效的策略。在胃癌方面,知识差距甚至更大,与其他已深入研究的癌症相比,关于缺氧的研究数量相对较少。全面综述HIF-1α诱导胃癌特征的分子机制,可为研究人员提供广阔的视角,并揭示未来研究中有待探索的缺失环节。因此,在此我们综述HIF-1α对癌症特征的影响,特别关注胃癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/e53daf32a6bd/cancers-14-02711-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/324b64c1b750/cancers-14-02711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/533051572cb3/cancers-14-02711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/e4e3fcfc5d8c/cancers-14-02711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/e53daf32a6bd/cancers-14-02711-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/324b64c1b750/cancers-14-02711-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/533051572cb3/cancers-14-02711-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/e4e3fcfc5d8c/cancers-14-02711-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/641d/9179860/e53daf32a6bd/cancers-14-02711-g004.jpg

相似文献

1
The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer.缺氧诱导因子-1α作为胃癌特征的强效诱导剂。
Cancers (Basel). 2022 May 30;14(11):2711. doi: 10.3390/cancers14112711.
2
The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting.缺氧诱导因子-1α在胃癌干性及化疗耐药中的作用:治疗靶点的未来方向
Front Cell Dev Biol. 2023 Feb 8;11:1082057. doi: 10.3389/fcell.2023.1082057. eCollection 2023.
3
HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.缺氧诱导因子-1α通过Snail信号通路诱导胃癌干细胞发生上皮-间质转化。
Oncotarget. 2017 Feb 7;8(6):9535-9545. doi: 10.18632/oncotarget.14484.
4
Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.晶状体细胞保护。第1部分:缺氧诱导因子-1α和-2α以及血管内皮生长因子在缺氧状态下晶状体上皮细胞存活中的作用。
Mol Vis. 2013;19:1-15. Epub 2013 Jan 2.
5
Targeting HIF-1α signaling pathway for gastric cancer treatment.靶向缺氧诱导因子-1α信号通路用于胃癌治疗。
Pharmazie. 2019 Jan 1;74(1):3-7. doi: 10.1691/ph.2019.8674.
6
Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis.缺氧诱导因子1α诱导的子宫内膜上皮细胞上皮-间质转化可能促进子宫内膜异位症的发生发展。
Hum Reprod. 2016 Jun;31(6):1327-38. doi: 10.1093/humrep/dew081. Epub 2016 Apr 19.
7
Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.胃上皮活性氧可防止胃癌细胞中缺氧诱导因子-1α的常氧降解。
Clin Cancer Res. 2003 Jan;9(1):433-40.
8
Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks.乳腺癌中的缺氧诱导因子-1α(HIF-1α):在癌症特征调控中与致癌因子和抑癌因子的相互作用。
Pathol Res Pract. 2023 Aug;248:154676. doi: 10.1016/j.prp.2023.154676. Epub 2023 Jul 7.
9
Hypoxia-inducible factor-1 in human breast and prostate cancer.人类乳腺癌和前列腺癌中的缺氧诱导因子-1
Endocr Relat Cancer. 2006 Sep;13(3):739-49. doi: 10.1677/erc.1.00728.
10
Is the hypoxia-inducible factor pathway important in gastric cancer?缺氧诱导因子通路在胃癌中重要吗?
Eur J Cancer. 2005 Dec;41(18):2792-805. doi: 10.1016/j.ejca.2005.09.008. Epub 2005 Nov 14.

引用本文的文献

1
A Novel Hypoxia-Immune Signature for Gastric Cancer Prognosis and Immunotherapy: Insights from Bulk and Single-Cell RNA-Seq.一种用于胃癌预后和免疫治疗的新型缺氧-免疫特征:来自批量和单细胞RNA测序的见解
Curr Issues Mol Biol. 2025 Jul 16;47(7):552. doi: 10.3390/cimb47070552.
2
RHOA-dependent regulation of mitochondrial remodeling and cell motility in hypoxia-exposed gastric epithelial cells.缺氧暴露的胃上皮细胞中线粒体重塑和细胞运动的RHOA依赖性调节
J Cell Sci. 2025 Jul 15;138(14). doi: 10.1242/jcs.263690. Epub 2025 Jul 30.
3
Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer.

本文引用的文献

1
The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study.2020 - 2040年185个国家胃癌的当前及未来发病率和死亡率:一项基于人群的建模研究
EClinicalMedicine. 2022 Apr 21;47:101404. doi: 10.1016/j.eclinm.2022.101404. eCollection 2022 May.
2
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.纳武利尤单抗联合化疗或伊匹单抗用于胃食管交界处癌。
Nature. 2022 Mar;603(7903):942-948. doi: 10.1038/s41586-022-04508-4. Epub 2022 Mar 23.
3
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
胃癌肿瘤微环境背景下髓源性抑制细胞的调控
Clin Transl Oncol. 2025 Jun 24. doi: 10.1007/s12094-025-03960-8.
4
Research progress on the therapeutic effects of effective components of traditional Chinese medicine in the treatment of gastric cancer precursors through modulation of multiple signaling pathways.中药有效成分通过调控多条信号通路治疗胃癌前体病变的研究进展
Front Oncol. 2025 May 19;15:1555274. doi: 10.3389/fonc.2025.1555274. eCollection 2025.
5
The Role of Hypoxia-Inducible Factor-1α (HIF-1α) in the Progression of Ovarian Cancer: Perspectives on Female Infertility.缺氧诱导因子-1α(HIF-1α)在卵巢癌进展中的作用:关于女性不孕症的观点
Cells. 2025 Mar 14;14(6):437. doi: 10.3390/cells14060437.
6
Transplantation of gastric epithelial mitochondria into human gastric cancer cells inhibits tumor growth and enhances chemosensitivity by reducing cancer stemness and modulating gastric cancer metabolism.将胃上皮线粒体移植到人类胃癌细胞中可通过降低癌症干性和调节胃癌代谢来抑制肿瘤生长并增强化学敏感性。
Stem Cell Res Ther. 2025 Feb 23;16(1):87. doi: 10.1186/s13287-025-04223-7.
7
Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.中医药治疗胃癌作用机制的深入见解
Front Oncol. 2025 Jan 21;14:1443686. doi: 10.3389/fonc.2024.1443686. eCollection 2024.
8
Integrating Network Pharmacology and In Silico Analysis to Explore the Bioactive Compounds Against Gastric Cancer Treatment.整合网络药理学与计算机模拟分析以探索抗胃癌治疗的生物活性化合物
Cureus. 2024 Dec 16;16(12):e75779. doi: 10.7759/cureus.75779. eCollection 2024 Dec.
9
Prediction of HIF-1α expression in endometrial carcinoma by enhanced T weighted angiography and dynamic contrast-enhanced magnetic resonance imaging.通过增强T加权血管造影和动态对比增强磁共振成像预测子宫内膜癌中HIF-1α的表达
Front Oncol. 2024 Dec 11;14:1439229. doi: 10.3389/fonc.2024.1439229. eCollection 2024.
10
Is Chronic Ice Water Ingestion a Risk Factor for Gastric Cancer Development? An Evidence-Based Hypothesis Focusing on East Asian Populations.长期饮用冰水是胃癌发生的危险因素吗?一项基于证据的针对东亚人群的假说。
Oncol Ther. 2024 Dec;12(4):629-646. doi: 10.1007/s40487-024-00299-y. Epub 2024 Sep 4.
《胃癌,第2.2022版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南》
J Natl Compr Canc Netw. 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008.
4
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.KEYNOTE-811 试验:双 PD-1 和 HER2 阻断在 HER2 阳性胃癌中的应用。
Nature. 2021 Dec;600(7890):727-730. doi: 10.1038/s41586-021-04161-3. Epub 2021 Dec 15.
5
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor.靶向缺氧诱导因子-1转录因子的抗癌药物最新进展概述
Cancers (Basel). 2021 Jun 4;13(11):2813. doi: 10.3390/cancers13112813.
6
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界癌和食管腺癌(CheckMate 649):一项随机、开放标签的3期试验。
Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5.
7
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications.胃癌中的肿瘤相关巨噬细胞与炎症微环境:新的转化意义
Int J Mol Sci. 2021 Apr 7;22(8):3805. doi: 10.3390/ijms22083805.
8
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.纳武利尤单抗辅助治疗食管或胃食管结合部癌。
N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125.
9
Current treatment and recent progress in gastric cancer.胃癌的当前治疗方法和最新进展。
CA Cancer J Clin. 2021 May;71(3):264-279. doi: 10.3322/caac.21657. Epub 2021 Feb 16.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.